Metagenomi, Inc. (MGX)
NASDAQ (NGS) NASDAQ (NGS) Primary 
The Schall Law Firm Is Looking Into Whether Metagenomi, Inc. Committed Securities Fraud And Stockholders Can Partake In The Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
MGX STOCK ALERT: Levi & Korsinsky Notifies Metagenomi, Inc. Investors of an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / September 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
Investors Are Urged To Reach Out To The Schall Law Firm About An Investigation Into Metagenomi Inc's Possible Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / September 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Metagenomi, Inc. (MGX)
NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metagenomi, Inc. - MGX
NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or the "Company") (NASDAQ:MGX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
MGX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you Lost Money on your Metagenomi, Inc. Investment
NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
Metagenomi, Inc. May Have Committed Securities Fraud And The Schall Law Firm Invites Affected Shareholders To Join An Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Metagenomi, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- MGX
NEW YORK, NY / ACCESSWIRE / September 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
The Schall Law Firm Is Looking Into Metagenomi Inc For Possible Securities Law Violations And Investors Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Metagenomi, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Metagenomi (MGX)
NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
Shareholder Rights Advocates at Levi & Korsinsky Investigate Metagenomi, Inc. (MGX) Regarding Possible Securities Fraud Violations
NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
MGX STOCK ALERT: Levi & Korsinsky Notifies Metagenomi, Inc. Investors of an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
